A weekly or monthly buprenorphine injection approved as an alternative long-acting option.
Speak with an addiction expert about whether Brixadi is right for you. Available 24/7. Confidential — no obligation.
(866) 353-8141 24/7 addiction helpline • Free & confidential • All calls welcomeBrixadi is a newer alternative to Sublocade, approved by the FDA in 2023. Like Sublocade, it delivers buprenorphine via injection — but Brixadi comes in both weekly and monthly formulations, offering more flexibility. The weekly formulation can be used for faster titration during induction, while the monthly formulation mirrors Sublocade's long-acting profile.
Because Brixadi is newer, not all providers stock or offer it. Call our helpline or contact listed providers directly to find one that prescribes Brixadi in your area. Insurance coverage is expanding rapidly as more health plans add Brixadi to their formularies.
Speak with an addiction expert about your treatment options. Available 24/7. Confidential — no obligation.
(866) 353-8141 24/7 addiction helpline • Free & confidential • All calls welcome